Matthias Breugelmans
Life science entrepreneur and CEO of Elastrin Therapeutics
Matthias Breugelmans is a life science entrepreneur and CEO of Elastrin Therapeutics. He has a master’s degree in Pharmaceutical Sciences and a PhD in Medicinal Chemistry. He worked in the pharmaceutical industry at Grünenthal in the Drug Safety department and later as OE / Business Transformation Consultant and Performance and Improvement Lead.
See also: Elastrin Therapeutics - South Carolina-based biotech developing novel therapies
Details last updated 06-Mar-2021
Matthias Breugelmans is also referenced in the following:
Longevity Summit Dublin 2023
17-Aug-2023 to 20-Aug-2023
Club discount available - click here
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Matthias Breugelmans News
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...Elastrin's novel therapies to reverse age-related vascular damage
Longevity Technology - 04-Mar-2021
Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo
Read more...